The reason for this observation is unclear, however BRCA2 gene mutation carriers are at a reduced overall breast cancer risk than BRCA1 gene mutation carriers (both alone and in combination with high MD), as shown in data generated from the Tyrer-Cuzik risk assessment calculator (Supplementary Table S1). This evidence concerns the gene BRCA2 and breast cancer.